Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013923 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
A Phase 2 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00013923: Completed Phase 2 study, sponsored by National Institute on Aging (NIA).
NCT00013923 is a Phase 2 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 40 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00013923, a Phase 2 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease.
Interventions
- DRUG Nutritional Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
What the finished NCT00013923 record still lists
NCT00013923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Nutritional Supplement is the first listed.
NCT00013923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00013923 about?
NCT00013923 is a clinical study titled "Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease". The purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease.
What is the current status of trial NCT00013923?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00013923?
The interventions under investigation include: Nutritional Supplement (DRUG).
Who is sponsoring clinical trial NCT00013923?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00013923's enrollment target sits among peer trials
40 1362nd of 2000 higher than 542 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models